L3Harris Technologies, Inc. (LHX) Stock Price & Analysis
L3Harris Technologies, Inc. (LHX) closed at USD 254.23 on Thursday, October 22, 2026, up 2.70% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 247.55; the Oct 22, 2026 session ranged USD 249.56–254.79 on volume of 1,888,766 shares. Market capitalization is $47.34B, with a 52-week range of USD 232.34–379.23 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:27 UTC.
Also available as compact Markdown for AI agents: nexqual.com/LHX.md
Key facts (LHX)
- Last four reported quarters (through Jul 3, 2026): revenue $39.1B, net income $1.87B (4.8% margin), free cash flow $2.81B (SEC filings).
- Valuation: P/E 25.3x (avg 33.3x at the last 3 fiscal year-ends), EV/EBITDA 10.9x, net debt $9.48B.
- 2 of 80 tracked superinvestors hold LHX (13F, Q2 2026): 0 new, 1 added, 0 reduced, 1 unchanged.
- Analysts: Buy (mean 2.35 on a 1–5 scale) (20 analysts), mean target USD 316.65 (range 241–393).
- Total return with dividends: 1Y -11.9% vs S&P 500 +14.9%; 5Y +14.8% vs S&P 500 +80.3%.
- Next earnings: 2026-10-29, EPS estimate USD 3.04, revenue estimate $5.94B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (LHX)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $17.8B | $17.1B | $19.4B | $21.3B | — | $39.1B |
| Gross profit | $5.38B | $4.93B | $5.11B | $5.52B | — | — |
| Operating income | $2.11B | $1.13B | $1.43B | $1.92B | $2.11B | $4.04B |
| Net income | $1.85B | $1.06B | $1.23B | $1.50B | $1.61B | $1.87B |
| EPS (diluted) | $9.09 | $5.49 | $6.44 | $7.87 | $8.53 | — |
| Free cash flow | $2.35B | $1.91B | $1.65B | $2.15B | $2.68B | $2.81B |
| Gross margin | 30.2% | 28.9% | 26.3% | 25.9% | — | — |
| Operating margin | 11.8% | 6.6% | 7.3% | 9.0% | — | 10.3% |
| Net margin | 10.4% | 6.2% | 6.3% | 7.0% | — | 4.8% |
| Revenue growth | -2.1% | -4.2% | +13.8% | +9.8% | — | — |
| Cash + short-term investments | $941M | $880M | $560M | $615M | $1.07B | — |
| Total debt | $7.06B | $7.04B | $12.8B | $11.7B | $11.1B | — |
Fiscal years end Jan. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jul 3, 2026) (LHX)
P/E 25.3x · P/S 1.2x · EV/EBITDA 10.9x · EV/Sales 1.4x · P/FCF 16.9x · P/B 2.4x · FCF yield 5.93% · Earnings yield 3.96% · Dividend yield (paid, TTM) 1.94% · Buyback yield (TTM) 1.81% · Net debt $9.48B · EV $56.8B
P/E at fiscal year-ends: Jan 2026 40.2x, Jan 2025 26.9x, Dec 2023 32.7x.
Superinvestors (SEC 13F-HR, Q2 2026) (LHX)
2 of 80 tracked investors hold LHX. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Yacktman Asset Management | 1.49% | $120M | Added +1.4% | |
| Mairs & Power | Mairs & Power Funds | <0.01% | $300K | Unchanged |
Analysts (LHX)
Consensus Buy (mean 2.35 on a 1–5 scale), 20 analysts; mean target USD 316.65 (low 241, high 393).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-15 | RBC Capital | Target lowered | Sector Perform | $310 → $265 |
| 2026-10-14 | Bernstein | Target lowered | Outperform | $346 → $318 |
| 2026-10-12 | Goldman Sachs | Target lowered | Buy | $405 → $361 |
| 2026-10-09 | TD Cowen | Target lowered | Buy | $370 → $280 |
| 2026-09-23 | Bernstein | Target lowered | Outperform | $365 → $346 |
| 2026-09-15 | Guggenheim | Initiated | Buy | $365 |
| 2026-08-03 | UBS | Target lowered | Neutral | $312 → $298 |
| 2026-07-31 | Susquehanna | Target lowered | Positive | $410 → $350 |
| 2026-07-30 | BNP Paribas | Target lowered | Neutral | $330 → $310 |
Total return (dividends reinvested) (LHX)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -11.9% | +14.8% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -11.9% | +2.8% |
| Volatility (annualized) | 28.4% | 25.0% |
| Max drawdown | -37.5% (Mar 2026→Oct 2026) | -36.3% (Feb 2022→Oct 2023) |
LHX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $3.04 | $3.07 | -0.9% | $5.94B | 9 |
| Next quarter (ends Dec 2026) | $3.20 | $3.17 | +0.8% | $6.00B | 9 |
| Current fiscal year (ends Dec 2026) | $12.09 | $11.80 | +2.4% | $23.56B | 10 |
| Next fiscal year (ends Dec 2027) | $13.51 | $13.59 | -0.6% | $25.29B | 10 |
Key Statistics (as of October 23, 2026 at 09:27 UTC)
| Price | USD 254.23 |
|---|---|
| Change | ▲ 2.70% (up) |
| Previous Close | USD 247.55 |
| Open | USD 249.16 |
| Day Range | USD 249.56 – 254.79 |
| 52-Week Range | USD 232.34 – 379.23 |
| Volume | 1,888,766 shares |
| Market Cap | $47.34B |
| Exchange | NYQ |
Technical Analysis (LHX)
Nexqual's technical model rates LHX "NEUTRAL" based on 4 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 09:27 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 61.85 (neutral) |
| vs SMA50 | Above (USD 251.72) |
| MACD | -0.51 (negative) |
Analyst Ratings (LHX)
Wall Street analysts rate LHX "Buy" based on 20 analysts, with a mean price target of USD 316.65 (range USD 241–393), per Nexqual as of October 23, 2026 at 09:27 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 20 |
| Mean Target | USD 316.65 |
| High Target | USD 393 |
| Low Target | USD 241 |
| Buy / Hold / Sell | 12 / 8 / 0 |
Earnings (LHX)
| Next Earnings Date | 2026-10-29 |
|---|---|
| EPS Estimate | USD 3.04 |
| Revenue Estimate | $5.94B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 3.63 vs est 2.84 ▲ beat |
| 2026-03-31 | USD 2.91 vs est 2.57 ▲ beat |
| 2025-12-31 | USD 2.86 vs est 2.76 ▲ beat |
| 2025-09-30 | USD 2.7 vs est 2.57 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financials & Fundamentals (LHX)
| Total Revenue | $22.93B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +8.40% |
| Gross Margin | +25.48% |
| Operating Margin | +12.57% |
| Profit Margin | +8.17% |
| ROE | +9.34% |
| Debt / Equity | 0.53 |
| Current Ratio | 1.18 |
| Total Cash | $1.52B |
| Total Debt | $11.00B |
| Free Cash Flow (last four quarters to Jul 2026, SEC 10-Q / 10-K) | $2.81B (7.2% of revenue) |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Financial Health Score (LHX)
Nexqual rates L3Harris Technologies, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:27 UTC.
| Growth | Mixed — Revenue +2.5% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 25%, operating 13% (last 12 months) |
| Balance Sheet | Solid — $1.52B cash and investments vs $11.0B debt (Jul 2026, SEC) |
| Cash Flow | Solid — FCF $2.81B (last 4 quarters to Jul 2026, SEC), 7% margin |
| Efficiency | Mixed — ROE 9%, ROA 4.4% |
Ownership (LHX)
| Insider Ownership | +0.45% |
|---|---|
| Institutional Ownership | +89.46% |
| Shares Outstanding | 186.21M |
| Float | 185.24M |
| Short % of Float | +2.78% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Leadership (LHX)
L3Harris Technologies, Inc. is led by Samir B. Mehta, CEO, President & Director, per Nexqual as of October 23, 2026 at 09:27 UTC.
| CEO, President & Director | Samir B. Mehta |
|---|---|
| President of Missile Solutions | Kenneth L. Bedingfield |
| Senior VP & CFO | Kenneth P. Sharp |
| Vice President of Operations & Program Excellence | David W. Zack |
| Vice President of Investor Relations & Corporate Development | Tony Calderon |
Major Backers & Investors (LHX)
Notable institutional backers of L3Harris Technologies, Inc. include Capital Group, Wellington Management, Wells Fargo & Company, according to Nexqual as of October 23, 2026 at 09:27 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capital Group | 3.55% |
| Wellington Management | 2.53% |
| Wells Fargo & Company | 2.42% |
| Morgan Stanley | 1.95% |
| Price (T.Rowe) Associates Inc | 1.77% |
| Fidelity | 1.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.69% |
| BlackRock | 10.21% |
| State Street | 4.89% |
| Geode Capital | 2.85% |
Source: Nexqual, October 23, 2026 at 09:27 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| HEI | Heico Corporation | USD 300.02 | ▲ 0.57% |
| HONA | Honeywell Aerospace Inc. | USD 163.02 | ▲ 0.34% |
| ESLT | Elbit Systems Ltd. | USD 743.22 | ▲ 0.07% |
| RKLB | Rocket Lab Corporation | USD 51.22 | ▼ 4.56% |
| TDG | Transdigm Group Incorporated | USD 1,141.74 | ▲ 1.09% |
| AXON | Axon Enterprise, Inc. | USD 414.6 | ▲ 2.98% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:27 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt